PHARMAC - Latest News [Page 1]

PHARMAC seeking views on new cystic fibrosis medicine

Friday, 24 January 2020, 1:01 pm | PHARMAC

PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) for people with cystic fibrosis. More >>

PHARMAC considering new medicines for type 2 diabetes

Wednesday, 15 January 2020, 4:44 pm | PHARMAC

PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living with type 2 diabetes. More >>

PHARMAC seeking views on new breast cancer medicine

Wednesday, 15 January 2020, 10:01 am | PHARMAC

PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) for first-line and second-line treatment of certain types of breast cancer. More >>

Spinraza funding application reviewed

Tuesday, 17 December 2019, 9:28 am | PHARMAC

PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for spinal muscular atrophy, is funded in New Zealand. More >>

PHARMAC to fund more cancer medicines and faster assessment

Thursday, 5 December 2019, 9:09 am | PHARMAC

Thousands of New Zealanders with lymphoma, breast, ovarian and blood cancers will have more treatment options available to them in the New Year. More >>

PHARMAC widening access to the meningococcal ACWY vaccine

Thursday, 14 November 2019, 9:38 am | PHARMAC

The meningococcal ACWY vaccine will be available free from next month for young people in close living situations. More >>

PHARMAC funding new leukaemia medicine

Monday, 4 November 2019, 10:19 am | PHARMAC

New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live longer from 1 December 2019. More >>

21,000 to benefit from Mirena and Jaydess

Monday, 14 October 2019, 9:27 am | PHARMAC

PHARMAC is widening funded access to Mirena, as well as listing a new long-acting reversible contraceptive option, Jaydess, which will benefit around 21,000 New Zealand women. More >>

PHARMAC signs bundle deal for more cancer medicines

Monday, 7 October 2019, 1:41 pm | PHARMAC

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More >>

Lamotrigine brand change from today

Tuesday, 1 October 2019, 12:42 pm | PHARMAC

From today there will be one funded brand of lamotrigine - a medicine used to treat epilepsy and some mental health conditions, including bipolar disorder. More >>

PHARMAC says more medicines on the way

Sunday, 1 September 2019, 3:47 pm | PHARMAC

PHARMAC says more medicines on the way PHARMAC has reached a deal with pharmaceutical companies for three new medicines to treat ovarian cancer, breast cancer and leukaemia. “The $60 million boost means we can make real inroads into funding medicines on ... More >>

Influenza vaccination levels hit near record levels

Thursday, 6 June 2019, 4:04 pm | PHARMAC

Director of Operations of Lisa Williams said this was the highest number of vaccines to have been distributed so early in winter. More >>

1500 New Zealanders access a cure for hepatitis C

Tuesday, 28 May 2019, 11:17 am | PHARMAC

Over 1500 New Zealanders have started a new hepatitis C treatment in the last three months that could dramatically change their lives. More >>

PHARMAC fully funding innovation in haemophilia treatment

Wednesday, 1 May 2019, 1:07 pm | PHARMAC

PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will make a major difference to their lives, PHARMAC Director of Operations Lisa Williams says. More >>

PHARMAC to give more clarity about funding decisions

Tuesday, 30 April 2019, 9:53 am | PHARMAC

An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and are not - being actively considered for funding, Chief Executive, Sarah Fitt says. More >>

PHARMAC funds potential Hepatitis C cure

Monday, 17 December 2018, 1:02 pm | PHARMAC

Life changing treatment for New Zealanders living with hepatitis C will be available from 1 February 2019, after PHARMAC funds a new treatment. The medicine known as Maviret (glecaprevir and pibrentasvir) can be prescribed to people with hepatitis ... More >>

PHARMAC celebrates NZ's Pacific Pharmacists’ Association

Friday, 24 August 2018, 2:15 pm | PHARMAC

PHARMAC is celebrating the formation of New Zealand’s first Pacific Pharmacists’ Association. More >>

Tapuhi Kaitiaki Awards for Māori Nurses launched

Thursday, 28 June 2018, 1:07 pm | PHARMAC

Tapuhi Kaitiaki Awards for Māori Nurses launched PHARMAC and Te Pōari o Te Rūnanga o Aotearoa/Tōpūtanga Tapuhi Kaitiaki o Aotearoa/New Zealand Nursing Organisation (NZNO) are pleased to announce the launch of the Tapuhi Kaitiaki Awards (Māori Nurses ... More >>

Community voices important to PHARMAC

Monday, 28 May 2018, 1:22 pm | PHARMAC

Community voices important to PHARMAC This year, PHARMAC is reviewing the way we seek and incorporate the consumer voice in our work, and is asking people about how we could improve input from, or engagement with, them. PHARMAC Chief Executive, Sarah ... More >>

PHARMAC widening access for Truvada

Wednesday, 7 February 2018, 2:04 pm | PHARMAC

PHARMAC widening access for Truvada for the prevention of HIV infection 7 February 2018 A decision to widen access to Truvada to prevent infection with HIV is a great opportunity to reduce transmission rates of HIV infections in New Zealand, says PHARMAC ... More >>



InfoPages Links